日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Unmasking FCGR2B as a high-grade serous ovarian cancer specific marker of immune suppression and tumor progression through multi-omics mining.

通过多组学挖掘揭示 FCGR2B 是高级别浆液性卵巢癌特异性免疫抑制和肿瘤进展标志物。

期刊:Translational Oncology
影响因子:4.1
doi:10.1016/j.tranon.2026.102748
Zhou Jialu, Zeng Tao, Ye Mingxia, Li Mingxia, Wen Liang, Liu Xinyi, Zhang Zhe, Meng Yuanguang
肿瘤
肿瘤免疫
卵巢癌
FCGR2B
免疫/内分泌
发表日期：2026
文献求助 收藏

Gene expression and machine learning techniques uncover corneal biomarkers associated with oxidative stress in the myopia progression.

基因表达和机器学习技术揭示了与近视进展过程中氧化应激相关的角膜生物标志物。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-026-46896-x
Zhou Qingyi, Ye Mingxia, Zhang Zhiyong, Luo Hongbo, Zhang Yonggang, Zhao Hailan
毒理研究
氧化应激
发表日期：2026
文献求助 收藏

FCGR2B (+) Macrophages as a Critical Node Linking Ferroptosis and Immunosuppression: A Multiomics Framework for Prognosis and Therapy in High-Grade Serous Ovarian Cancer

FCGR2B(+)巨噬细胞作为连接铁死亡和免疫抑制的关键节点：高级别浆液性卵巢癌预后和治疗的多组学框架

期刊:Human Mutation
影响因子:3.7
doi:10.1155/humu/8027584
Zhou, Jialu; Zeng, Tao; Liu, Yi; Ye, Mingxia; Li, Mingxia; Zhang, Zhe; Meng, Yuanguang
巨噬细胞
肿瘤
肿瘤免疫
巨噬细胞
铁死亡
卵巢癌
FCGR2B
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

GSDME-mediated pyroptosis is essential for the chemotherapeutic effects achieved by combined treatment of temsirolimus and 5-fluorouracil in ovarian carcinoma cells.

GSDME介导的细胞焦亡对于替西罗莫司和5-氟尿嘧啶联合治疗卵巢癌细胞所达到的化疗效果至关重要。

期刊:American Journal of Translational Research
影响因子:1.6
doi:10.62347/TJWX5574
Chen Zhenbo, Ye Mingxia, Gu Chenglei, Wen Na, Wang Nan, Meng Yuanguang
肿瘤
表观遗传
GSDME
肿瘤免疫
卵巢癌
焦亡
细胞生物学
发表日期：2026
文献求助 收藏

Spatial ecostructural modelling of endometrial cancer identifies the key role of CD90 + CD105 + endothelial cells in tumour heterogeneity and predicts disease recurrence

子宫内膜癌的空间生态结构模型揭示了CD90+CD105+内皮细胞在肿瘤异质性中的关键作用，并预测了疾病复发。

期刊:Experimental Hematology & Oncology
影响因子:13.5
doi:10.1186/s40164-025-00724-6
Wu, Di; Lv, Cinian; Yan, Zhifeng; Zhao, Luyang; Li, Lian; Ye, Mingxia; Wang, Mingyang; Zhai, Qingzhi; Wang, Nan; Wang, Zheng; Meng, Yuanguang; Li, Mingxia
肿瘤
子宫内膜癌
CD105
肿瘤免疫
CD9
CD10
肿瘤异质性
内皮细胞
细胞生物学
CD90
发表日期：2025
文献求助 收藏

Integrated analysis of microbiome and metabolome reveals insights into cervical neoplasia aggravation in a Chinese cohort

对微生物组和代谢组的综合分析揭示了中国人群宫颈肿瘤恶化的机制

期刊:Frontiers in Cellular and Infection Microbiology
影响因子:4.8
doi:10.3389/fcimb.2025.1556153
Zhai, Qingzhi; Zhao, Luyang; Wang, Mingyang; Li, Li; Li, Li-An; Ye, Mingxia; Li, Mingxia; Xu, Chengfeng; Meng, Yuanguang
微生物学
肿瘤
肿瘤免疫
代谢
发表日期：2025
文献求助 收藏

Association of sodium-glucose cotransporter-2 inhibitor use and mortality in patients with endometrial cancer: a retrospective cohort study

钠-葡萄糖协同转运蛋白-2抑制剂的使用与子宫内膜癌患者死亡率的相关性：一项回顾性队列研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14453-w
Wang, Min; Ye, Mingxia; Lucero, Maria; Pan, Wanchun; Wang, Xin; Zhang, Heping; Zhou, Ling; Meng, Yuanguang
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Management of pregnant women with endocervical and decidual polyps: a systematic review and meta-analysis

妊娠期宫颈内膜息肉和蜕膜息肉的管理：系统评价和荟萃分析

期刊:Archives of Gynecology and Obstetrics
影响因子:2.5
doi:10.1007/s00404-025-08056-w
Wang, Min; Ye, Mingxia; Shen, Nan; Pan, Wanchun; Zhang, Heping; Wang, Xin; Sun, Tingyu; Zhou, Ling; Meng, Yuanguang
发表日期：2025
文献求助 收藏

Case Report and Review of Literature: Camrelizumab Combined with Fuzuloparib and Apatinib for Platinum-Resistant Recurrent Ovarian Cancer

病例报告及文献综述：卡瑞利珠单抗联合夫索洛帕尼和阿帕替尼治疗铂类耐药复发性卵巢癌

期刊:Oncotargets and Therapy
影响因子:2.8
doi:10.2147/OTT.S375643
Wu, Yawen; Zhang, Xiaoyan; Li, Lian; Yang, Wen; Yan, Zhifeng; Gu, Chenglei; Zhang, Zhe; Zhou, Jiahuan; Liu, Lulu; Ye, Mingxia; Meng, Yuanguang
肿瘤
肿瘤免疫
卵巢癌
发表日期：2022
文献求助 收藏

Robotic-Assisted Laparoscopic Sacrocolpopexy for Pelvic Organ Prolapse: A Single Center Experience in China

机器人辅助腹腔镜骶骨阴道固定术治疗盆腔器官脱垂：中国单中心经验

期刊:Journal of Healthcare Engineering
影响因子:
doi:10.1155/2022/6201098
Niu, Ke; Zhai, Qingzhi; Fan, Wensheng; Li, Li'an; Yang, Wen; Ye, Mingxia; Meng, Yuanguang
发表日期：2022
文献求助 收藏